Bolus Med Spa

06/03/2026

The best summer skin care products for elevated results!
(Budget edition)

05/24/2026

05/22/2026

The most important sunscreen is a one year willing to use every day.

Tinted sunscreens provide extra protection which can be extremely important for folks with melasma.

These are the ones I use daily, especially around laser care.

DM SPF for link

Mark Abbott, CRNP Creator of The Prime Method Expert concierge care bridging advanced aesthetics and root-cause wellness. Serving Elkridge, Maryland and surrounding areas. I help discerning patients optimize hormones, metabolism, skin health, and vitality for lasting results — not quick fixes. Ready to invest in your best self? DM me to schedule a consultation.

05/20/2026

The best summer hack for melasma

Most people think melasma only comes from the sun.

But heat alone can worsen pigmentation too.

That’s why every summer we see patients frustrated because their discoloration suddenly flares — even when they “weren’t really outside.”

Pigmentation management is about consistency, inflammation control, and protecting the skin properly.

Especially during Maryland summers.

Book a call to discuss treatment options best suited for you and your situation. My team is ready to help! #

— Mark Abbott, CRNP
Bolus Med Spa | Elkridge, Maryland

TintedSPF SkincareTips Pigmentation HealthySkin MedicalAesthetics

05/17/2026

Symptoms of PMOS

For years, many women are told:“Your labs look normal.”

Meanwhile their body is quietly struggling with: hormonal dysfunction, insulin resistance, chronic inflammation, nutrient depletion, and metabolic imbalance.

This is bigger than weight.

It affects: energy, confidence, sleep, mood, relationships, performance, and quality of life.

There is a difference between surviving… and actually feeling well.

Mark Abbott, CRNP Creator of The Prime Method Expert concierge care bridging advanced aesthetics and root-cause wellness. Serving Elkridge, Maryland and surrounding areas. I help discerning patients optimize hormones, metabolism, skin health, and vitality for lasting results — not quick fixes. Ready to invest in your best self? DM me to schedule a consultation.

A limited number of comprehensive hormone and metabolic consultations are currently being accepted for qualified patients seeking a deeper evaluation and personalized treatment approach.

11/04/2025

🚨 GLP-1s & Your BOTOX: What the New Study Says and why your treatment may not last as long💉

If you’re taking a GLP-1 receptor agonist (like Ozempic, Mounjaro, or Wegovy) and also get type A neurotoxin like Botox, you need to see this! A new computational study suggests that GLP-1 medications may reduce the durability of your botulinum toxin treatments.

Here are the key statistics from the computational model:
* Chronic Migraine Treatment: The mean duration of effect for BoNT-A (Botox) declined from 14.0 weeks (in controls) to as low as 11.8 weeks in patients with high GLP-1 exposure.
* Aesthetic Treatments (Masseter Prominence): The mean duration of effect decreased from 20.1 weeks (in controls) to a minimum of 16.2 weeks.
* Drug Hierarchy: The study suggested the effect varied by drug, with the greatest reduction in duration modeled for tirzepatide (Mounjaro/Zepbound), followed by liraglutide, then dulaglutide, and finally semaglutide (Ozempic/Wegovy).

* The Cause: The reduction in durability was attributed primarily to synaptic modulation (~55%)—the drug’s effect on nerve signaling—and lean-mass decline (~30%).

The Bottom Line: If you’re on a GLP-1, you may need to schedule your Botox touch-ups sooner than before. While not specifically implied, this would include compounded medications as well.

⚠️ Always consult your healthcare provider and injector to discuss any medications you are taking and to tailor your treatment plan!

The Study and Link:
* Title: Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications
* Link (PubMed): Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A